Rare tumors, major challenges: The RACOON-SAGA project explores how imaging and clinical data can improve the pre-therapeutic characterization of soft tissue sarcomas. In this interview, Dr. Madelaine Hettler from University Medical Center Mannheim explains how radiology and surgery collaborate within the Network University Medicine — and why structured data are key to making therapy decisions more precise and personalized.

Rare Tumors, Big Goals: How RACOON-SAGA Aims to Improve Therapy Decisions
Related Resources
Related Resources

Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…

RACOON – Imaging, Data & Collaboration for Better Decisions
Modern radiology faces a central question: how can imaging and clinical data be combined in a way that leads to more precise diagnoses,…

Rethinking Early Detection: How RACOON-MARDER Aims to Spot Liver Cancer Sooner
Hepatocellular carcinoma (HCC) is often diagnosed too late, limiting treatment options and survival. The RACOON-MARDER project aims to change that. By…